Joseph Scheeren insider trades

Open-market stock purchases and sales by Joseph Scheeren, Director at Barinthus Biotherapeutics plc., from SEC Form 4 filings since Apr 29, 2021.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • BRNS Barinthus Biotherapeutics plc.: other filings, last Jun 10, 2025
  • VACC Vaccitech plc: 3 buys, last Jun 26, 2023

Get free alerts when Joseph Scheeren files a new trade →